Supreme Court: Federal law pre-empts state suits over drug label shortcomings

The Supreme Court has ruled that generic drug manufacturers cannot be sued in state court for potential warning label shortcomings in the generic version of a federally approved drug.In Mutual Pharmaceutical Co. v. Bartlett, the court ruled 5-4, agreeing with the generic drug manufacturer’s contention that federal law pre-empts a New Hampshire law that allowed a strict product liability lawsuit by Karen L. Bartlett.

Full Story →